Form 483

Aliri USA Inc. Form 483, 2009-02-12

FDA issued a Form 483 to Aliri USA Inc. on 2009-02-12 with 5 public-safe observations.

483· Form 483 issued5 observations

Aliri USA Inc. · Colorado Springs, United States · Issued February 12, 2009

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Feb 2009
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Linda M Cherry, Matthew R Dionne, James D Bradley, Terri L Thomas

12 Feb 2009
21 CFR 211.56(a)

Sanitation--buildings not clean, free of infestation

Cited by Linda M Cherry, Matthew R Dionne, James D Bradley, Terri L Thomas

12 Feb 2009
21 CFR 211.56(c)

Written procedures lacking for use of pesticides etc.

Cited by Linda M Cherry, Matthew R Dionne, James D Bradley, Terri L Thomas

12 Feb 2009
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Linda M Cherry, Matthew R Dionne, James D Bradley, Terri L Thomas

12 Feb 2009
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Linda M Cherry, Matthew R Dionne, James D Bradley, Terri L Thomas

Inspected site

AUAliri USA Inc.Colorado Springs, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.56(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere